Advanced experience in the treatment of diabetes in developed countries in Europe and America

according to the International Diabetes Federation (IDF) released the latest data report: the United States, Britain, France, Germany and other developed countries in Europe and the United States diabetes diabetes blood sugar compliance rate of 80%, the incidence of complications less than 15%, most patients normal life, and the average life expectancy is 8-10 years longer than ChinaWhat is the cause of sugar friends, the west of the same disease different lives of the result? Insulin is not the best "sugar fighter" insulin is the only protein hormone in the body that lowers blood sugarTraditional insulin treatments can have temporary results, but after a period of use, the effect decreases and increases insulin resistanceTherefore, in developed countries in Europe and the United States, although the prevalence of insulin injection is very high, but this is not the root cause of their low incidence of diabetes complications and mortalityThe relative leading stem cell technology in developed countries From a global perspective, stem cell technology research and application is developing rapidly and has broad prospectsHowever, at present, stem cell therapy is not academically certified, stem cells can treat or cure many diseases, but also with a certain risk of ease of useThe most important is the rapid growth of stem cell division, in vitro culture 10-50 generation cancer rate greatly increased, therefore, the Chinese Food and Drug Administration (CFDA) in the "stem cell preparation quality control and preclinical research guidelines (trial)" requires stem cell preparations must be sexually carcinogenic testing inside and outside the bodyAt present, many non-professional institutions engaged in stem cell therapy do not have a special carcinogenic test, the safety of treatment is not fundamentally guaranteed.
In Europe and the United States and other developed regions, stem cell research, application has formed a better standards and regulationsGermany, the United States, Canada, the United Kingdom, New Zealand and other advanced medical countries have a more clear, sophisticated and strict management system for this technologyThis ensures the standardization, safety and effectiveness of this advanced technology in the course of operationSelecting the best stem cells by the German TICEBA Stem Cell Center used "ABCB5 positive dermal intermymal protoscopic stem cells", because of its proliferation differentiation ability, no risk of tumor, no ethical disputes, and can regulate immune balance and other advantages, is generally considered to be the most suitable for diabetes treatment stem cells.
Because ABCB5 stem cells in the purification, culture process there is a high technical difficulty, the world only The German TICEBA Stem Cell Center has exclusive patent authorizationIn data released by the TICEBA Center in 2013, more than 250 diabetics from around the world received treatment, the vast majority of patients through treatment to reduce the amount of medication, physical function gradually into a higher state, more active fight against diabetes, in addition, there are some patients, in cooperation with doctors, have been free from the trouble of sugar or insulin, can eat like a normal person.